Gabrail Cancer Center
4875 Higbee Ave NW
Canton, Ohio 44718
330-492-3345 http://www.gabrailcancercenter.com/home.php CantonDesk©GabrailCancerCenter.com

Use our guide to learn which trials are right for you!

Since 1990, Gabrail Cancer Center has built a national reputation for excellence in cancer patient care, management, diagnosis, research, education, and prevention. 



Gabrail Cancer Center, founded by Nash Gabrail M.D., M.R.C.P., opened its community practice in Stark County in 1990. Then due to the increasing amount of patients traveling long distance for treatment, a satellite office was opened in Tuscarawas county in 1999. In 2005, due to the expansion of the Clinical Trials and the addition of Diagnostic Imaging, Gabrail Cancer Center relocated in Stark county to increase its square footage by 400%. Gabrail Cancer Center is constantly renovating and expanding to meet the growing needs of patients and the community.



GCC experts have established standards of care and treatment protocols for each type and stage of cancer. Dr. Gabrail has an extraordinary depth and breadth of experience in diagnosing and treating all forms of the disease, from the most common to the very rare. Each year, he treats more than 200 different subtypes of cancer. This level of specialization can have an often-dramatic effect on patients chances for a cure or control of their cancer. And while GCC is known for our advanced, innovative therapies, our physician is equally well regarded for his compassion and concern.



GCC's patient-focused philosophy is supported by the Center's beautiful architecture and a variety of services that span the full range of practical and emotional needs. GCC has high standards for patient satisfaction and offer exceptional value in cancer care. Financial counselors on staff coordinate with patients to assist them in meeting the expenses of treatment and applying for pharmaceutical assistance programs.

We've found
19 trials
at this facility
Hematology, Oncology, Other Clinical Trial
A Phase 2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Myelofibrosis
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Canton, OH
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Elevate CLL TN: Study of Obinutuzumab + Chlorambucil, Acalabrutinib (ACP-196) + Obinutuzumab, and Acalabrutinib in Subjects With Previously Untreated CLL
Status: Enrolling, Phase III
Updated: 8/8/2016
mi
from
Canton, OH
Click here to add this to my saved trials
Oncology Clinical Trial
TR(ACE) Assay Clinical Specimen Study
Status: Enrolling
Updated: 1/16/2018
mi
from
Canton, OH
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Pomalidomide for Lenalidomide for Relapsed or Refractory Multiple Myeloma Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Canton, OH
Click here to add this to my saved trials
Hematology Clinical Trial
KRT-232 in Subjects With PMF, Post-PV MF, or Post-ET MF Who Have Failed a JAK Inhibitor
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Canton, OH
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of PTC299 in Relapsed/Refractory Acute Leukemias
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Canton, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Effect of Food on Blood Levels of ASTX727
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Canton, OH
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Weekly 70 mg/m2 Carfilzomib for Multiple Myeloma Patients Refractory to 27 mg/m2 Carfilzomib
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Canton, OH
Click here to add this to my saved trials
Stage III/IV Melanoma Clinical Trial
Tavo and Pembrolizumab in Patients With Stage III/IV Melanoma Progressing on Pembrolizumab or Nivolumab Treatment
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Canton, OH
Click here to add this to my saved trials
Polycythemia Vera Clinical Trial
KRT-232 Compared to Ruxolitinib in Patients With Phlebotomy-Dependent Polycythemia Vera
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Canton, OH
Click here to add this to my saved trials
Solid Tumors Clinical Trial
Tomivosertib (eFT-508) in Combination With PD-1/PD-L1 Inhibitor Therapy
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Canton, OH
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Canton, OH
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Patients With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Canton, OH
Click here to add this to my saved trials
Neoplasms Clinical Trial
First-in-human Study of ATR Inhibitor BAY1895344 in Patients With Advanced Solid Tumors and Lymphomas
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Canton, OH
Click here to add this to my saved trials
Carcinoma, Non-Small-Cell Lung Clinical Trial
VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Canton, OH
Click here to add this to my saved trials
Non-small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC), Colorectal Cancer (CRC), Hepatocellular Carcinoma (HCC) Clinical Trial
An Study to Evaluate the Safety and Efficacy of Copanlisib in Combination With Nivolumab in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Canton, OH
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
Status: Enrolling, Phase II
Updated: 1/16/2014
mi
from
Canton, OH
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
A Study of Combination Therapies With Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Canton, OH
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
A Study to Assess the Safety and Efficacy of Intratumoral IMO-2125 in Combination With Ipilimumab or Pembrolizumab in Patients With Metastatic Melanoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Canton, OH
Click here to add this to my saved trials